Anne M. Bonser
University of Western Australia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anne M. Bonser.
Biochemical and Biophysical Research Communications | 1985
P. Garcia-Webb; Anne M. Bonser
Isolated hepatocytes from streptozotocin injected rats bound the same amount of [125I]monoiodoinsulin as hepatocytes from control rats. Scatchard analysis confirmed that insulin receptor number and affinity were the same for both groups. Relatively more cell-associated radioactivity was located intracellularly in hepatocytes from streptozotocin injected rats. Pretreatment with chloroquine resulted in a smaller increase in intracellular [125I]monoiodoinsulin in cells isolated from streptozotocin injected rats than for control cells. These results suggest that intracellular insulin processing occurs more slowly in hepatocytes isolated from streptozotocin injected rats than from control rats.
Diabetologia | 1984
P. Garcia-Webb; Paul Zimmet; Anne M. Bonser; H. King; S. Bottomley
SummaryFasting serum C-peptide immunoreactivity was determined on Nauruans, a Micronesian population with a high prevalence of diabetes. In Micronesian subjects neither age nor gender had a significant effect on fasting serum C-peptide. In non-diabetic subjects, as has been shown previously for Caucasiod subjects, both obesity and fasting plasma glucose levels were determinants of fasting serum C-peptide. Obesity was the major determinant. Taken overall, mean fasting serum C-peptide increased then possibly fell in subjects grouped by increasing 2-h post-glucose plasma glucose levels. Mean fasting serum C-peptide in newly-diagnosed diabetic subjects was greater than that in non-diabetic subjects with a similar degree of obesity, supporting the concept that the transition to diabetes may be associated with an increase in insulin resistance. The data for non-diabetic subjects were compared with serum C-peptide measured in the same laboratory on samples from a Caucasoid population in Busselton, Western Australia. There was no difference in fasting serum C-peptide level between Micronesian and Caucasoid subjects approximately matched for obesity and fasting plasma glucose levels.
Biochimica et Biophysica Acta | 1983
Anne M. Bonser; P. Garcia-Webb; Chotoo I. Bhagat
Previous studies have suggested that transglutaminase has a role in the internalization of some polypeptide hormones and is inhibited by the antibiotic, bacitracin. Bacitracin has been used in insulin-receptor studies to inhibit extracellular degradation of 125I-labelled insulin. The aim of this study was to investigate bacitracins effect on 125I-labelled insulin-receptor interactions in isolated rat hepatocytes. 1 g/l bacitracin increased cell-associated 125I-labelled insulin insulin at 20, 30 and 37 degrees C (P less than 0.001, 0.0005 and 0.0005, respectively). At 5 and 15 degrees C (internalization does not occur), bacitracin did not affect cell-associated 125I-labelled insulin. The bacitracin effect was concentration dependent, increasing to 2 g/l. Scatchard analysis showed that bacitracin did not alter insulin receptor affinity or number. 1 g/l bacitracin abolished the effect of chloroquine. The increased cell-associated radioactivity with bacitracin was surface-bound in nature. 0.5 g/l bacitracin decreased 125I-labelled insulin degradation in hepatocyte suspensions (P less than 0.001) and in buffer previously incubated with hepatocytes (P less than 0.0005). More 125I-labelled insulin remained associated with cells during dissociation studies at 37 degrees C when the buffer contained 1 g/l bacitracin. Label that appeared in the buffer after 60 min was significantly more intact in the presence of bacitracin (P less than 0.025). These results suggest that bacitracin retards the internalization of 125I-labelled insulin in isolated rat hepatocytes.
Biochemical and Biophysical Research Communications | 1984
Anne M. Bonser; P. Garcia-Webb
Isolated rat hepatocytes were incubated for 1 h at 37 degrees C with 10 nM insulin. Following washout of insulin, cells were incubated with [125I] monoiodoinsulin at 15 degrees C to assess surface insulin binding. Preincubation with 10 nM insulin did not cause a decrease in insulin binding. Scatchard analysis confirmed that insulin receptor number remained constant. In the presence of 200 microM chloroquine or 25 microM monensin, surface insulin binding after preincubation with 10 nM insulin fell to 81.1 +/- 1.2% or 39.0 +/- 2.7% of control, respectively. It is suggested that the maintenance of insulin receptor number following acute insulin treatment in vitro is due to an insulin receptor recycling pathway, possibly involving lysosomes and/or the Golgi apparatus.
Pathology | 1982
P. Garcia-Webb; Anne M. Bonser; J. Pelham; D. Whiting
Summary Seven out of 206 subjects investigated at6‐mth intervals with a glucose tolerance test developed non‐insulin dependent diabetes. The mean fasting serum C‐peptide concentration in the diabetic subjects was greater at the time of diagnosis of diabetes than 6 mth prior to diagnosis (1.25 and 1.01 nmol/l respectively, p < 0.05). There was no significant difference in mean ideal body weight and maximum post‐glucose serum C‐peptide reactivity (CPR) before and at diagnosis. There was no change in mean fasting CPR during a similar 6 mth period (0.84 and 0.84 nmol/l respectively) in 17 subjects with normal glucose tolerance matched with the diabetics for age and ideal body weight. It is postulated that at least in some subjects the transition to diabetes is accompanied by an increase in insulin resistance.
Clinica Chimica Acta | 1982
P. Garcia-Webb; Anne M. Bonser; D. Whiting
Clinica Chimica Acta | 1979
P. Garcia-Webb; Anne M. Bonser
Clinica Chimica Acta | 1983
P. Garcia-Webb; Steven Bottomley; Anne M. Bonser
Immunology and Cell Biology | 1983
Anne M. Bonser; P. Garcia-Webb; Chotoo I. Bhagat
Scandinavian Journal of Clinical & Laboratory Investigation | 1983
P. Garcia-Webb; Anne M. Bonser; David A. Whiting; John R. L. Masarei